Estrogen found to increase growth of the most common childhood brain tumor

Feb 17, 2009

University of Cincinnati (UC) researchers have discovered that estrogen receptors are present in medulloblastoma—the most common type of pediatric brain tumor—leading them to believe that anti-estrogen drug treatments may be beneficial in limiting tumor progression and improving patients' overall outcome.

This research is being published in the March 2009 edition of Endocrinology.

In estrogen-responsive cancers—such as breast cancer—estrogen receptors act to increase tumor growth and progression. Estrogen receptors are also the most important drug targets for the treatment of breast cancer.

"Current therapies for medulloblastoma involve cranial surgery, chemotherapy and radiation," says Scott Belcher, PhD, principal investigator of the study. "This discovery suggests that we may be able to use anti-hormone or estrogen drug therapies—like those used to treat breast cancers—to limit progression of these childhood brain tumors and to decrease the adverse side-effects of radiation treatment."

Medulloblastoma, or MD, is a highly malignant brain tumor, most commonly diagnosed in children.

Patients with MD typically have a five-year survival rate between 50 and 70 percent, and survivors who endure current, more aggressive treatments face an increased risk for chronic illnesses such as diabetes or cardiovascular disease later in life.

Belcher, an associate professor in the department of pharmacology and cell biophysics at UC, and his team examined tumor tissue from 22 patients between the ages of 6 months and 18 years.

They found evidence of estrogen receptors, particularly estrogen receptor beta, in the cancerous cells of every tumor analyzed.

"MD manifests when specific neuron precursors in the brain fail to stop normally differentiating into mature neurons," Belcher says. "Our previous studies showed that estrogen receptors are regulated during differentiation of these neuronal precursors. MD growth and tumor cell formation can be blocked by inhibiting the activity of these receptors."

Belcher said these results demonstrate the importance of "bench to bedside" discoveries.

"We started in tumor cells and then moved to animal models of MD and found that we could stop the growth of tumors using anti-estrogen therapies," he says. "We've been able to identify these receptors in humans. We are now hoping that our basic developmental biology findings can take the final step by stopping the growth of these tumors in humans."

"We believe that development of rational anti-estrogen drug therapies for this highly malignant cancer is a possibility and could improve the lives of many children and adult survivors," he continues.

Source: University of Cincinnati

Explore further: New cancer vaccine approach directly targets dendritic cells

add to favorites email to friend print save as pdf

Related Stories

Clue to unusual drug-resistant breast cancers found

Oct 08, 2010

Researchers at the University of Illinois at Chicago College of Medicine have found how gene expression that may contribute to drug resistance is ramped up in unusual types of breast tumors. Their findings may offer new therapy ...

Enzyme helps cancer cells avoid genetic instability

Jan 21, 2013

Cancer cells are resourceful survivors with plenty of tricks for staying alive. Researchers have uncovered one of these stratagems, showing how cells lacking the tumor suppressor BRCA1 can resume one form ...

Cincinnati professor nominated for Nobel dies (Update)

Dec 21, 2012

(AP)—Elwood Jensen, an award-winning University of Cincinnati professor nominated for the Nobel Peace Prize for work that opened the door to advances in fighting cancer, has died of pneumonia. He was 92.

Protein structures give disease clues

Feb 01, 2012

Using some of the most powerful nuclear magnetic resonance equipment available, researchers at the University of California, Davis, are making discoveries about the shape and structure of biological molecules ...

Recommended for you

Physicians target the genes of lung, colon cancers

6 hours ago

(Medical Xpress)—University of Florida physicians and researchers are collaborating to map the genes of different types of cancer, and then deliver medication to attack cancer at its source.

User comments : 0

More news stories

How kids' brain structures grow as memory develops

Our ability to store memories improves during childhood, associated with structural changes in the hippocampus and its connections with prefrontal and parietal cortices. New research from UC Davis is exploring ...

Gate for bacterial toxins found

Prof. Dr. Dr. Klaus Aktories and Dr. Panagiotis Papatheodorou from the Institute of Experimental and Clinical Pharmacology and Toxicology of the University of Freiburg have discovered the receptor responsible ...

Adventurous bacteria

To reproduce or to conquer the world? Surprisingly, bacteria also face this problem. Theoretical biophysicists at Ludwig-Maximilians-Universitaet (LMU) in Munich have now shown how these organisms should ...